We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 100Kg
Contract Manufacturing: CMO
Packaging Information: Barrel
Delivery Lead Time: 1 Month
Sample Provided: yes
Payment Terms: T/T
Acetazolamide
【CAS No.】59-66-5
【Formula 】C4H6N4O3S2
【GMP National Medicine Permission Number】H11020232
【Drug Class】Carbonic anhydrase inhibitor
【Formulation Use】 Acetazolamide Tablet(0.25g)
【Packing Specification】20kg/Barrel
【Standard】 CP, EP,USP,BP ,ect
【Description】:
Acetazolamideis a carbonic anhydrase inhibitor used to treat edema from heart failureor medications, certain types of epilepsy, and glaucoma.One of the carbonic anhydrase inhibitors that is sometimes eff ective against absenceseizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic,myoclonic, and atonic seizures, particularly in women whose seizures occur or areexacerbated at specifi c times in the menstrual cycle. However, its usefulness is transientoft en because of rapid development of tolerance. Its antiepileptic eff ect may be due toits inhibitory eff ect on brain carbonic anhydrase, which leads to an increasedtransneuronal chloride gradient, increased chloride current, and increased inhibition.